Byron Martina
@bmartina.bsky.social
Byron holds a degree in infection and immunity and a Ph.D. in virology. He is committed to advancing the field of viro-immunology through cutting-edge research and development.
#www.artemisbioservices.com
#www.artemisbioservices.com
January 17, 2025 at 11:27 PM
January 17, 2025 at 11:19 PM
We’ve developed a low-dose, low-volume H5N1 intranasal ferret challenge model to advance influenza antiviral and vaccine research. Using only 50 µL per nare and 100 TCID50 of H5N1. This physiologically relevant approach avoids the FDA’s concerns with high-dose models.
#Influenza #ArtemisBiosciences
#Influenza #ArtemisBiosciences
January 17, 2025 at 11:16 PM
We’ve developed a low-dose, low-volume H5N1 intranasal ferret challenge model to advance influenza antiviral and vaccine research. Using only 50 µL per nare and 100 TCID50 of H5N1. This physiologically relevant approach avoids the FDA’s concerns with high-dose models.
#Influenza #ArtemisBiosciences
#Influenza #ArtemisBiosciences